For most cancer patients, Original Medicare + Medigap Plan G + a thoughtfully-chosen Part D plan is the best Medicare structure because it provides the maximum provider network freedom (critical for accessing top oncologists and centers of excellence) and predictable costs throughout treatment. Cancer-specific Special Needs Plans (C-SNPs) exist but have limited availability.
Why provider freedom matters in cancer care:
Cancer treatment increasingly involves:
- Specialized oncologists (medical, surgical, radiation)
- NCI-designated Comprehensive Cancer Centers
- Clinical trials (often only at academic medical centers)
- Multi-disciplinary tumor boards
- Specialized imaging (PET, MRI, advanced molecular testing)
- Newer therapies (immunotherapy, CAR-T cell therapy, targeted molecular drugs)
Most Medicare Advantage HMO networks don't include all the major cancer centers. PPO MA plans offer broader access but at higher cost-sharing for out-of-network. Original Medicare is accepted by virtually every cancer center in the U.S. including Memorial Sloan Kettering, MD Anderson, Mayo Clinic, Cleveland Clinic, Dana-Farber, etc.
Specific Medicare cancer coverage:
Part A covers:
- Inpatient hospital stays for treatment
- Skilled nursing facility care after qualifying hospital stay
- Hospice (when life expectancy is 6 months or less)
- Some home health services
Part B covers:
- Outpatient chemotherapy (delivered in clinical settings)
- Radiation therapy
- Surgical procedures (outpatient)
- Diagnostic imaging (MRI, CT, PET, mammography)
- Lab work (CBC, tumor markers, biopsies)
- Doctor visits (oncologist, surgeon, primary care)
- Durable medical equipment (port supplies, prostheses)
- Wigs (for chemotherapy-induced hair loss — counted as DME)
- Lymphedema compression garments (newly covered as of 2024)
- Some specialty drugs administered in-office (NOT pills you take at home)
Part D covers:
- Oral chemotherapy drugs (e.g., capecitabine, ibrutinib, palbociclib)
- Hormone therapies (tamoxifen, anastrozole, letrozole, exemestane)
- Anti-nausea medications
- Pain management drugs
- Other oral oncology agents
The cost trap — specialty drug coinsurance:
Many oral cancer drugs cost $5,000–$15,000+/month at retail. Pre-2025, Part D required 25–33% coinsurance on these in the catastrophic phase, leading to $1,500–$5,000/month copays.
The 2026 Part D $2,000 cap is a game-changer for cancer patients. Once you spend $2,000 out-of-pocket on covered Part D drugs in a year, you pay $0 for the rest of the year. For a patient on a $10,000/month oral chemotherapy:
- January: $2,000 out-of-pocket → cap reached
- February–December: $0
- Annual total Part D out-of-pocket: $2,000
Use the Medicare Prescription Payment Plan (M3P) to spread the $2,000 across 12 monthly payments ($166.67/month) instead of paying upfront.
Plan structure recommendations:
Path 1 (recommended for most cancer patients) — Original Medicare + Medigap Plan G + Part D:
- Original Medicare: full coverage at any cancer center nationally
- Medigap Plan G: covers all 20% coinsurance under Part B (chemo, radiation, surgery, imaging) after $283 annual Part B deductible
- Part D: choose plan based on your specific medications + the $2,000 OOP cap protection
Total annual out-of-pocket exposure for medical: $283 (Part B deductible). Drug exposure: capped at $2,000.
Total worst-case: ~$2,283 + Medigap premium (~$2,400/yr) + Part D premium (~$500/yr) = ~$5,200/year
Path 2 — Cancer C-SNP (if available in your county):
- Specialized network for cancer care (oncologists, infusion centers, radiation facilities)
- Often $0 premium
- Tailored formulary for oncology drugs
- Care coordinator assigned
- Limited availability — only in select counties
Downside: Network may not include the specific cancer center where you want treatment.
Path 3 — PPO Medicare Advantage:
- Allows out-of-network with higher cost-sharing
- Useful if your local PCP is HMO-friendly but you want option for distant cancer center
- Higher OOP max ($9,350+ in 2026)
- Less predictable than Original Medicare + Medigap
Path 4 — HMO Medicare Advantage (riskiest for cancer patients):
- Lowest premium
- Network may not include specialized cancer centers or clinical trial sites
- Prior authorization for many treatments
- If your preferred oncologist isn't in network, you'd have to switch providers or pay full out-of-pocket
- Generally NOT recommended for active cancer patients with specific provider preferences
Specific decision factors for cancer patients:
- Are you currently in active treatment? Don't switch plans during active treatment if possible — start-over deductibles, network changes, and prior auth resets can disrupt care.
- Where do you want to be treated? Verify your preferred cancer center accepts the plan you're considering. Original Medicare = accepted virtually everywhere; MA plans = check directly.
- Are you considering clinical trials? Original Medicare covers routine costs of clinical trial participation. MA plans must too, but the trial site must accept the MA plan.
- What's your tax-and-IRMAA situation? Cancer treatment can push high-income retirees into higher IRMAA brackets. Coordinate with your tax advisor.
- Should you consider hospice? When prognosis is 6 months or less, Medicare hospice provides comprehensive end-of-life care at $0 to the member. Election of hospice means electing not to pursue curative treatment for the terminal illness.
- Long-term care planning: Original Medicare doesn't cover long-term custodial care. If your treatment may require months of nursing care, plan for self-pay, long-term care insurance, or Medicaid eligibility.
Newly diagnosed cancer triggers a Special Enrollment Period:
In some states, a new cancer diagnosis can trigger guaranteed-issue Medigap rights — meaning you can buy a Medigap policy without medical underwriting. Check your state's specific rules.
At any point during cancer treatment, you can:
- Switch Part D plans during AEP (Oct 15 – Dec 7) for a better-fitting formulary
- Add or change Medicare Advantage during AEP
- Switch from Original Medicare to MA during AEP
- Switch from MA to Original Medicare during AEP or OEP (Jan 1 – Mar 31)
- Use the 12-month MA trial right if you joined MA at 65 within last year
What to do next: Call (866) 534-1886. We work with cancer patients on Medicare plan selection during diagnosis, treatment decisions, and end-of-life planning. Free, with care taken to coordinate around your active treatment schedule. Includes verifying that your specific oncologist and treatment center accept any plan we recommend.